15-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1062 19 991 108 1315 188 1144
ERLYTX 78 1 52 2 24 6 37
GI 187 3 157 15 183 23 140
GU 406 5 261 24 292 46 280
LEUK 136 3 157 8 97 17 103
LUNG 181 6 313 19 231 32 195
LYMPH 391 11 574 38 463 57 347
MELAN 246 0 0 0 0 0 0
MMYEL 118 1 52 6 73 11 67
MULT 23 0 0 0 0 1 6
OTHER 43 1 52 4 49 8 49
PREV 2 0 0 0 0 0 0
SXQOL 2 0 0 0 0 0 0
Total 2875 50 2609 224 2727 389 2368

15-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  1 1 52 1 12 1 6
CCD 125 5 261 18 219 31 189
ERLYTX 10 0 0 0 0 0 0
GU 1 0 0 1 12 1 6
LEUK 620 10 522 51 621 97 590
LUNG 332 9 470 34 414 57 347
OTHER 35 0 0 1 12 2 12
PEOLC 121 0 0 1 12 6 37
PREV 226 3 157 22 268 39 237
SXQOL 572 14 730 46 560 81 493
Total 2043 42 2192 175 2130 315 1917

15-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  1 1 52 1 12 1 6
BREAST 1062 19 991 108 1315 188 1144
CCD 125 5 261 18 219 31 189
ERLYTX 88 1 52 2 24 6 37
GI 187 3 157 15 183 23 140
GU 407 5 261 25 304 47 286
LEUK 756 13 678 59 718 114 694
LUNG 513 15 783 53 645 89 542
LYMPH 391 11 574 38 463 57 347
MELAN 246 0 0 0 0 0 0
MMYEL 118 1 52 6 73 11 67
MULT 23 0 0 0 0 1 6
OTHER 78 1 52 5 61 10 61
PEOLC 121 0 0 1 12 6 37
PREV 228 3 157 22 268 39 237
SXQOL 574 14 730 46 560 81 493
Total 4918 92 4800 399 4857 704 4286

15-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 684 12 626 77 937 135 822
ERLYTX 44 1 52 1 12 3 18
GI 134 1 52 10 122 14 85
GU 338 4 209 17 207 38 231
LEUK 83 2 104 7 85 13 79
LUNG 114 3 157 13 158 22 134
LYMPH 252 7 365 22 268 37 225
MELAN 155 0 0 0 0 0 0
MMYEL 73 1 52 2 24 6 37
MULT 8 0 0 0 0 0 0
OTHER 43 1 52 4 49 8 49
PREV 2 0 0 0 0 0 0
SXQOL 2 0 0 0 0 0 0
Total 1932 32 1669 153 1862 276 1680

15-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  1 1 52 1 12 1 6
CCD 110 5 261 16 195 27 164
ERLYTX 10 0 0 0 0 0 0
GU 1 0 0 1 12 1 6
LEUK 263 5 261 19 231 37 225
LUNG 209 5 261 18 219 32 195
OTHER 35 0 0 1 12 2 12
PEOLC 86 0 0 1 12 5 30
PREV 226 3 157 22 268 39 237
SXQOL 391 9 470 33 402 58 353
Total 1332 28 1462 112 1363 202 1228

15-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  1 1 52 1 12 1 6
BREAST 879 17 887 96 1169 169 1029
CCD 144 4 209 15 183 29 177
ERLYTX 54 1 52 1 12 3 18
GI 138 1 52 9 110 14 85
GU 361 4 209 22 268 43 262
LEUK 346 7 365 26 317 50 304
LUNG 330 8 417 33 402 60 365
LYMPH 252 7 365 22 268 37 225
MELAN 155 0 0 0 0 0 0
MMYEL 66 1 52 2 24 6 37
MULT 28 0 0 3 37 5 30
OTHER 243 3 157 10 122 24 146
PEOLC 89 1 52 2 24 6 37
PREV 228 3 157 22 268 39 237
SXQOL 393 9 470 33 402 58 353
Total 3707 67 3496 297 3618 544 3311

15-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 876 17 887 83 1011 145 883
ERLYTX 74 1 52 2 24 6 37
GI 109 2 104 10 122 15 91
GU 249 4 209 18 219 36 219
LEUK 102 2 104 4 49 9 55
LUNG 147 6 313 17 207 27 164
LYMPH 317 7 365 29 353 44 268
MMYEL 104 0 0 5 61 8 49
MULT 23 0 0 0 0 1 6
Total 2001 39 2034 168 2046 291 1772

15-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 1906 34 1774 154 1875 276 1680
AFFIL 141 0 0 15 183 28 170
CCOP/NCORP 1217 26 1357 96 1169 174 1059
Non-SWOG 1654 32 1670 134 1631 226 1376
Total 4918 92 4801 399 4858 704 4285

15-FEB-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
ERLYTX SN2426 cSCC, IC Met/Inop, Amivantamab v Cetuximab 1 Y 28-JAN-26

15-FEB-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
GU S2210 Pros, High Risk, BRCA, Neoadj Carbo 1 T 21-JAN-26
GU S2200 pRCC, Adv, Cabo ± Atezo 1 T 16-JAN-26
OTHER NRGBN011 Brain, Lomustine + Temo vs Temo 1 E 12-FEB-26
OTHER NRGBN011 Brain, Lomustine + Temo vs Temo 2 E 12-FEB-26
OTHER A071701 BRAIN, Met, Geno-guided trial 0 E 05-FEB-26
OTHER A071701 BRAIN, Met, Geno-guided trial 1 E 05-FEB-26

15-FEB-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 15
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 14
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 10
LUNG LUNGMAP NSCLC, Adv, Master 1 9
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 9
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 2 8
LUNG LUNGMAP NSCLC, Adv, Master 2 5
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 5
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 4
CCD S2417CD Colrec Surv, Follow-up w/ CTAC site 1 4
LYMPH AHOD2131 cHL,StgI-II,StdTherapyvImmuno-oncologyTherapy 1 3
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 3